Can Cutaneous Leishmaniasis Provoke a Resurgence of Kala-azar in the Indian Subcontinent?

Overview

Journal BMC Infect Dis

Publisher Biomed Central

Specialty Infectious Diseases

Date 2025 Feb 26

PMID 40012028

Authors

Narayan Raj Bhattarai

Keshav Rai

Surendra Uranw

Dhan Keshar Khadka

Basudha Khanal

Gokarna Dahal

Sushmita Pradhan

Sushil Dhakal

Pieter Monsieurs

Tanyth de Gooyer

Kristien Cloots

Epco Hasker

Gert Van der Auwera

Affiliations

Soon will be listed here.

Abstract

Background: The ongoing kala-azar elimination program in Nepal is based on the assumption of anthroponotic transmission of the protozoan parasite Leishmania donovani. This parasite species was recently also found in lesions of cutaneous leishmaniasis (CL) cases, which are increasingly reported mainly from western Nepal. The question whether or not CL causing L. donovani can also contribute to VL is a crucial one to answer if the success of the VL elimination initiative in the Indian subcontinent is to be sustained, though evidence on sub-species level genomic differences between CL and VL causing L. donovani is currently lacking. This study aims to provide a genomic comparison of L. donovani parasites currently causing CL in Nepal with previously described L. donovani isolates.

Methods: A case series study was carried out in sentinel dermatological sites in Western Nepal. Skin punch biopsies were collected from clinically suspected CL lesions. Molecular tests based on the ribosomal RNA gene array were used to detect and characterize the Leishmania parasites.

Results: Leishmania parasites detected in 26 cutaneous leishmaniasis patients were identified as L. donovani. Importantly, their analyzed DNA sequences were identical, and shared with previously documented sequences from both cutaneous and visceral disease-causing parasites in Nepal, India and Bhutan.

Conclusions: Our study suggests that CL and VL are caused by similar if not identical L. donovani parasite strains, though additional sequencing is required to corroborate this finding. If confirmed, cutaneous lesions could act as a kala-azar parasite reservoir, which would have important implications for the kala-azar elimination program.

References

Roy L, Cloots K, Uranw S, Rai K, Bhattarai N, Smekens T . The ongoing risk of Leishmania donovani transmission in eastern Nepal: an entomological investigation during the elimination era. Parasit Vectors. 2023; 16(1):404. PMC: 10629032. DOI: 10.1186/s13071-023-05986-9. View

Lypaczewski P, Chauhan Y, Paulini K, Thakur L, Chauhan S, Roy E . Emerging Leishmania donovani Lineages Associated with Cutaneous Leishmaniasis, Himachal Pradesh, India, 2023. Emerg Infect Dis. 2024; 30(9):1957-1959. PMC: 11346985. DOI: 10.3201/eid3009.231595. View

Van der Auwera G, Ravel C, Verweij J, Bart A, Schonian G, Felger I . Evaluation of four single-locus markers for Leishmania species discrimination by sequencing. J Clin Microbiol. 2014; 52(4):1098-104. PMC: 3993476. DOI: 10.1128/JCM.02936-13. View

Rai T, Shrestha S, Prajapati S, Bastola A, Parajuli N, Ghimire P . Leishmania donovani persistence and circulation causing cutaneous leishmaniasis in unusual-foci of Nepal. Sci Rep. 2023; 13(1):12329. PMC: 10387047. DOI: 10.1038/s41598-023-37458-6. View

Yangzom T, Cruz I, Bern C, Argaw D, den Boer M, Dario Velez I . Endemic transmission of visceral leishmaniasis in Bhutan. Am J Trop Med Hyg. 2012; 87(6):1028-37. PMC: 3516070. DOI: 10.4269/ajtmh.2012.12-0211. View

Downing T, Imamura H, Decuypere S, Clark T, Coombs G, Cotton J . Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance. Genome Res. 2011; 21(12):2143-56. PMC: 3227103. DOI: 10.1101/gr.123430.111. View

Pandey K, Bastola A, Haiyan G, Pyakurel U, Pandey B, Dumre S . Emergence of cutaneous leishmaniasis in Nepal. Trop Med Health. 2021; 49(1):72. PMC: 8428101. DOI: 10.1186/s41182-021-00359-3. View

Monsieurs P, Cloots K, Uranw S, Banjara M, Ghimire P, Burza S . Source Tracing of Leishmania donovani in Emerging Foci of Visceral Leishmaniasis, Western Nepal. Emerg Infect Dis. 2024; 30(3):611-613. PMC: 10902524. DOI: 10.3201/eid3003.231160. View

Schonian G, Nasereddin A, Dinse N, Schweynoch C, Schallig H, Presber W . PCR diagnosis and characterization of Leishmania in local and imported clinical samples. Diagn Microbiol Infect Dis. 2003; 47(1):349-58. DOI: 10.1016/s0732-8893(03)00093-2. View

10.

Zhang W, Ramasamy G, McCall L, Haydock A, Ranasinghe S, Abeygunasekara P . Genetic analysis of Leishmania donovani tropism using a naturally attenuated cutaneous strain. PLoS Pathog. 2014; 10(7):e1004244. PMC: 4081786. DOI: 10.1371/journal.ppat.1004244. View

11.

Thakur L, Singh K, Shanker V, Negi A, Jain A, Matlashewski G . Atypical leishmaniasis: A global perspective with emphasis on the Indian subcontinent. PLoS Negl Trop Dis. 2018; 12(9):e0006659. PMC: 6159859. DOI: 10.1371/journal.pntd.0006659. View

12.

Lypaczewski P, Thakur L, Jain A, Kumari S, Paulini K, Matlashewski G . An intraspecies hybrid from the Indian subcontinent is associated with an atypical phenotype of cutaneous disease. iScience. 2022; 25(2):103802. PMC: 8841885. DOI: 10.1016/j.isci.2022.103802. View

13.

Imamura H, Downing T, Van den Broeck F, Sanders M, Rijal S, Sundar S . Evolutionary genomics of epidemic visceral leishmaniasis in the Indian subcontinent. Elife. 2016; 5. PMC: 4811772. DOI: 10.7554/eLife.12613. View

14.

Uranw S, Bhattarai N, Cloots K, Roy L, Rai K, Kiran U . Visceral leishmaniasis in the hills of western Nepal: A transmission assessment. PLoS One. 2024; 19(4):e0289578. PMC: 11023194. DOI: 10.1371/journal.pone.0289578. View

15.

Fathima P, Shah H, Sivalaxmi B, Haritha H, Ajithlal P, Aiswarya R . Genetic diversity of Leishmania donovani causing visceral and cutaneous leishmaniasis in the Western Ghats, India. Gene. 2024; 928:148803. DOI: 10.1016/j.gene.2024.148803. View